| 1 HAM‐A score, buspirone vs diazepam |
1 |
19 |
Mean Difference (IV, Random, 95% CI) |
‐0.20 [‐7.45, 7.05] |
| 1.2 Buspirone vs diazepam |
1 |
19 |
Mean Difference (IV, Random, 95% CI) |
‐0.20 [‐7.45, 7.05] |
| 2 HAM‐A score, buspirone vs lorazepam |
1 |
40 |
Mean Difference (IV, Fixed, 95% CI) |
1.10 [0.29, 1.91] |
| 2.1 Buspirone vs lorazepam |
1 |
40 |
Mean Difference (IV, Fixed, 95% CI) |
1.10 [0.29, 1.91] |
| 3 HAM‐A score, buspirone vs alprazolam |
1 |
39 |
Mean Difference (IV, Fixed, 95% CI) |
1.10 [0.28, 1.92] |
| 4 Number of people who drop out |
12 |
1444 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.24 [1.01, 1.52] |
| 4.2 Buspirone vs benzodiazepine |
12 |
1444 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.24 [1.01, 1.52] |
| 5 Specific side effects, buspirone |
9 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 5.1 Nausea |
3 |
304 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.84 [1.14, 7.09] |
| 5.2 Decreased cognition |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.21 [0.01, 4.11] |
| 5.3 Dizziness |
3 |
295 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.28 [1.15, 4.54] |
| 5.4 Headaches |
3 |
573 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.41 [0.76, 2.63] |
| 5.5 Restlessness |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 5.6 Drowsiness |
3 |
621 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.29 [0.21, 0.41] |
| 5.7 Lethargy |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.08 [0.00, 1.34] |
| 5.8 Lighheadedness |
2 |
112 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.82 [0.27, 2.52] |
| 5.9 Fatigue |
4 |
476 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.24 [0.13, 0.45] |
| 5.10 Infection |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.11 [0.21, 21.36] |
| 5.11 Constipation |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.05 [0.07, 15.66] |
| 5.12 Coryza |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.15 [0.14, 72.88] |
| 5.13 Faintness |
1 |
2 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 5.14 Gastrintestinal distress |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.35 [0.02, 8.10] |
| 5.15 Nervousness |
2 |
248 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.17 [0.06, 0.47] |
| 5.16 Tremor |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.21 [0.01, 4.11] |
| 5.17 Weakness |
2 |
285 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.42 [0.15, 1.12] |
| 5.18 Depression |
4 |
909 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.22 [0.12, 0.39] |
| 5.19 Insomnia |
1 |
209 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.14 [0.03, 0.63] |
| 5.20 Dry mouth |
3 |
338 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.52 [0.22, 1.26] |
| 5.21 Sleepiness |
2 |
92 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.34 [0.10, 1.17] |
| 5.22 Tinnitus |
1 |
19 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.73 [0.12, 59.57] |
| 5.23 Unsteadiness |
1 |
19 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.30 [0.01, 6.62] |
| 5.24 Sleep Problems |
1 |
66 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.25 [0.08, 0.81] |
